A new program to boost U.S. drug manufacturing with streamlined processes, regulatory support. Read more here.

The FDA Thursday announced a program that seeks to strengthen domestic drug manufacturing by increasing regulatory ...

On July 30, 2025, the U.S. Department of Justice (DOJ) announced that biotechnology company Illumina Inc. agreed to pay $9.8 million plus interest ...

A deep dive into the implications of the Replimune CRL that surprised insiders and investors, the role of new leadership at ...

Arquitos Capital Management gained 13.1% in Q2 2025. Learn how they turned market uncertainty into opportunity with Liquidia ...

As artificial intelligence (AI) becomes increasingly embedded in health care, from diagnostics and clinical decision support to ...

The FDA's generative AI, Elsa, has a massive hallucination problem, according to the agency's employees themselves.

The US Food and Drug Administration appears poised to continue with a plan to ban prescription fluoride supplements at a time when many experts say that access to the products has become ...

But a new report from CNN confirms all our worst fears. Elsa, the FDA’s AI tool, is spitting out fake studies.

Today's biotech news includes Sean Parker and ARCH launching a cancer biotech, the FDA's concerns about Sarepta, and more.

The FDA issued an early alert related to an issue with Novum IQ large-volume infusion pumps made by Baxter (NYSE:BAX). This notice comes just weeks after an initial warning about potential ...